Hhlr Advisors, Ltd. Portfolio Holdings

Hhlr Advisors, Ltd.

  • $4.36 Billion
  • Q3 2024

Hhlr Advisors, Ltd. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $4.36 Billion distributed in 48 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bei Gene, Ltd. with a value of $1.16B, Alibaba Group Holding LTD with a value of $937M, Pinduoduo Inc. with a value of $643M, Legend Biotech Corp with a value of $323M, and Vipshop Holdings LTD with a value of $247M.

Examining the 13F form we can see an increase of $494M in the current position value, from $3.87B to 4.36B.

Hhlr Advisors, Ltd. is based out at Grand Cayman, E9

Below you can find more details about Hhlr Advisors, Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $4.36 Billion
Consumer Cyclical: $2.05 Billion
Healthcare: $1.57 Billion
Communication Services: $288 Million
Real Estate: $216 Million
Financial Services: $101 Million
Industrials: $75.8 Million
Technology: $53.1 Million
ETFs: $5.57 Million
Other: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$20.1B
$1.16 Billion 26.65% of portfolio
5,176,906
Q2 2023 Reduced 5.4%
$230B
$937 Million 21.48% of portfolio
8,827,600
Q3 2024 Added 64.1%
$147B
$643 Million 14.73% of portfolio
4,766,780
Q3 2024 Reduced 46.4%
$6.72B
$323 Million 7.41% of portfolio
6,636,496
Q2 2024 Added 10.89%
$8.61B
$247 Million 5.67% of portfolio
15,720,322
Q3 2024 Added 6.18%
$57.5B
$242 Million 5.55% of portfolio
2,588,943
Q3 2024 Added 86.82%
$25.7B
$216 Million 4.96% of portfolio
10,868,688
Q3 2024 Reduced 53.1%
$41.6B
$105 Million 2.42% of portfolio
1,774,432
Q3 2024 Added 28.15%
$13.1B
$101 Million 2.31% of portfolio
1,051,089
Q3 2024 Added 46.78%
$16.2B
$74.4 Million 1.71% of portfolio
3,003,008
Q3 2024 Added 8,172.75%
$54.9B
$64 Million 1.47% of portfolio
1,600,000
Q3 2024 Added 2,522.95%
$663M
$47.2 Million 1.08% of portfolio
4,975,183
Q4 2021 New
$825M
$36.9 Million 0.85% of portfolio
6,657,030
Q2 2023 Reduced 13.58%
$30B
$31.6 Million 0.72% of portfolio
300,000
Q3 2024 New
$19.8B
$30 Million 0.69% of portfolio
665,863
Q3 2024 New
$3.42B
$26.1 Million 0.6% of portfolio
1,023,950
Q3 2024 Reduced 26.37%
$420M
$11.2 Million 0.26% of portfolio
713,400
Q1 2024 Reduced 2.51%
$81.4M
$8.57 Million 0.2% of portfolio
6,909,220
Q2 2023 Reduced 0.65%
$65.8M
$4.92 Million 0.11% of portfolio
4,974,041
Q4 2022 Reduced 32.97%
$977B
$3.37 Million 0.08% of portfolio
19,395
Q3 2024 Reduced 70.97%
$0
$2.86 Million 0.07% of portfolio
100,000
Q3 2024 Reduced 16.67%
$884M
$2.58 Million 0.06% of portfolio
1,564,400
Q1 2024 Reduced 2.21%
$190M
$2.8 Million 0.06% of portfolio
3,949,700
Q2 2023 Reduced 1.44%
$0
$2.7 Million 0.06% of portfolio
79,500
Q3 2024 New
$170B
$2.53 Million 0.06% of portfolio
9,104
Q3 2024 Reduced 91.62%
$1.26T
$2.29 Million 0.05% of portfolio
4,000
Q3 2024 Reduced 91.01%
$17M
$2.17 Million 0.05% of portfolio
847,510
Q1 2023 Reduced 2.65%
$387M
$1.56 Million 0.04% of portfolio
918,892
Q3 2023 New
$134M
$1.4 Million 0.03% of portfolio
382,606
Q2 2023 Reduced 27.9%
$362M
$1.14 Million 0.03% of portfolio
600,000
Q2 2024 New
$86.9B
$712,000 0.02% of portfolio
1,502
Q3 2024 Reduced 62.73%
$2.58B
$1.09 Million 0.02% of portfolio
30,000
Q3 2024 New
$194B
$1.08 Million 0.02% of portfolio
5,713
Q3 2024 Reduced 37.89%
$95.3B
$292,000 0.01% of portfolio
753
Q3 2024 Reduced 84.82%
Arrivent Biopharma Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 14.14%
Yatsen Hldg LTD
-
$0 0.0% of portfolio
-
Q1 2024 New
China Jo Jo Drugstores Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Bright Scholar Ed Hldgs LTD
-
$0 0.0% of portfolio
-
Q3 2023 Reduced 0.49%
Zeekr Intelligent Technology
-
$0 0.0% of portfolio
-
Q2 2024 New
Contineum Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2024 New
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Ge Vernova Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 19.36%
Sagimet Biosciences Inc
-
$0 0.0% of portfolio
-
Q1 2024 Reduced 50.0%
Lakeshore Biopharma CO LTD
-
$0 0.0% of portfolio
-
Q1 2023 New
Metagenomi Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Kiniksa Pharmaceuticals Intl
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 49.67%
Uxin LTD
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 48
  • Current Value $4.36 Billion
  • Prior Value $3.87 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Hhlr Advisors, Ltd. Portfolio

Follow Hhlr Advisors, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Hhlr Advisors, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email